Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 29
2021 35
2022 30
2023 29
2024 16
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of turmeric for the treatment of COVID-19: An updated systematic review and meta-analysis of randomized controlled trials.
Sawangjit R, Sadoyu S, Manosanthipaibul S, Teerawattanapong N, Puttarak P, Wanaratna K, Charoensup R, Hiransai P, Meetam T, Chaiyakunapruk N. Sawangjit R, et al. Complement Ther Med. 2025 Oct 31;95:103295. doi: 10.1016/j.ctim.2025.103295. Online ahead of print. Complement Ther Med. 2025. PMID: 41176175 Free article. Review.
We conducted a comprehensive and updated systematic review and meta-analysis (SR-MA) to determine the effectiveness and safety of turmeric in patients with coronavirus disease 2019 (COVID-19). Multiple databases were searched from inception to July 31, 2024, …
We conducted a comprehensive and updated systematic review and meta-analysis (SR-MA) to determine the effectiveness and safety of turmeri …
[Herbal treatment options for post-viral symptoms and long COVID].
Krassnig K, Bauer R, Glasl S, Haubenberger P, Evanzin HJ, Schneider K, Margotti D. Krassnig K, et al. Wien Med Wochenschr. 2025 Oct 29. doi: 10.1007/s10354-025-01113-8. Online ahead of print. Wien Med Wochenschr. 2025. PMID: 41160239 Review. German.
BACKGROUND: Long COVID and post-viral symptom complexes have become a significant focus in medical practice. ...The review identified the most relevant medicinal plants and their preparations for the most common symptom complexes of long COVID. RESULTS: A total of 9 …
BACKGROUND: Long COVID and post-viral symptom complexes have become a significant focus in medical practice. ...The review identified …
Global, regional, and national sepsis incidence and mortality, 1990-2021: a systematic analysis.
GBD 2021 Global Sepsis Collaborators. GBD 2021 Global Sepsis Collaborators. Lancet Glob Health. 2025 Oct 21:S2214-109X(25)00356-0. doi: 10.1016/S2214-109X(25)00356-0. Online ahead of print. Lancet Glob Health. 2025. PMID: 41135560 Free article.
We aimed to comprehensively estimate the global, regional, and national burden of sepsis, including the impact of the COVID-19 pandemic and underlying causes of sepsis-related deaths with co-occurring infectious syndromes. ...In 2021, bloodstream infections inclusiv …
We aimed to comprehensively estimate the global, regional, and national burden of sepsis, including the impact of the COVID-19 …
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Causes of Death Collaborators. GBD 2023 Causes of Death Collaborators. Lancet. 2025 Oct 18;406(10513):1811-1872. doi: 10.1016/S0140-6736(25)01917-8. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092928 Free PMC article.
Methodological improvements for cause-of-death estimates in GBD 2023 include a correction for the misclassification of deaths due to COVID-19, updates to the method used to estimate COVID-19, and updates to the CODEm modelling framework. ...By 2023, …
Methodological improvements for cause-of-death estimates in GBD 2023 include a correction for the misclassification of deaths due to COVI …
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Demographics Collaborators. GBD 2023 Demographics Collaborators. Lancet. 2025 Oct 18;406(10513):1731-1810. doi: 10.1016/S0140-6736(25)01330-3. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092927 Free PMC article.
BACKGROUND: Comprehensive, comparable, and timely estimates of demographic metrics-including life expectancy and age-specific mortality-are essential for evaluating, understanding, and addressing trends in population health. The COVID-19 pandemic highlighted the imp …
BACKGROUND: Comprehensive, comparable, and timely estimates of demographic metrics-including life expectancy and age-specific mortality-are …
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
Remarkable health gains were made for communicable, maternal, neonatal, and nutritional (CMNN) diseases, with DALYs falling from 874 million (837-917) in 2010 to 681 million (642-736) in 2023, and a 25.8% (22.6-28.7) reduction in age-standardised DALY rates. During the COVID …
Remarkable health gains were made for communicable, maternal, neonatal, and nutritional (CMNN) diseases, with DALYs falling from 874 million …
A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19.
Saleh Z, Asgari MR, Ghorbani R, Babamohamadi H. Saleh Z, et al. Sci Rep. 2025 Aug 21;15(1):30793. doi: 10.1038/s41598-025-16092-4. Sci Rep. 2025. PMID: 40841392 Free PMC article. Clinical Trial.
Inflammation and immune mediators exacerbate COVID-19; turmeric and ginger possess antiviral and anti-inflammatory properties that may mitigate this response. This study compared the effects of turmeric and ginger on inflammatory markers in patients wi …
Inflammation and immune mediators exacerbate COVID-19; turmeric and ginger possess antiviral and anti-inflammatory prop …
Prevalence, patterns, drivers, and perceived benefits of herbal medicine use in COVID-19 patients in Qatar.
Alsheikh R, Alsharif FR, Alwisi N, Nazar Z, Syed MA, Qotba HA, Al-Mansoori L, Shi Z, Shaito AA. Alsheikh R, et al. J Pharm Policy Pract. 2025 Jul 23;18(1):2533258. doi: 10.1080/20523211.2025.2533258. eCollection 2025. J Pharm Policy Pract. 2025. PMID: 40709240 Free PMC article.
BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged as a global health crisis in early 2020, leading to widespread morbidity and mortality. ...CONCLUSION: Herbal me …
BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS- …
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Vaccine Coverage Collaborators. GBD 2023 Vaccine Coverage Collaborators. Lancet. 2025 Jul 19;406(10500):235-260. doi: 10.1016/S0140-6736(25)01037-2. Epub 2025 Jun 24. Lancet. 2025. PMID: 40578370 Free PMC article.
However, more recent decades have seen persistent coverage inequities and stagnating progress, which have been further amplified by the COVID-19 pandemic. In 2019, WHO set ambitious goals for improving vaccine coverage globally through the Immunization Agenda 2030 ( …
However, more recent decades have seen persistent coverage inequities and stagnating progress, which have been further amplified by the C …
Turmeric and Eucalyptus Aqueous Extracts Reduced Inflammation in Macrophage Activation Syndrome (MAS) Mouse Model.
Al-Omari MM, Al-Yousef MM, Al-Qaoud KM, Bataineh NM. Al-Omari MM, et al. J Inflamm Res. 2025 Jun 11;18:7599-7610. doi: 10.2147/JIR.S518419. eCollection 2025. J Inflamm Res. 2025. PMID: 40524970 Free PMC article.
Due to the high number of cytokine storm patient deaths, mainly those that occurred during the COVID-19 pandemic and the lack of effective treatments against CSS spectrums, many people returned to nature and used plant-based remedies at the household level. METHODS: …
Due to the high number of cytokine storm patient deaths, mainly those that occurred during the COVID-19 pandemic and the lack …
139 results